Spots Global Cancer Trial Database for Betrnet Stem Cells and the Origins of Barrett's Esophagus Project 3 RF Ablation
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Betrnet Stem Cells and the Origins of Barrett's Esophagus Project 3 RF Ablation
Official Title: Stem Cells And The Origins Of Barrett's Esophagus:Identification Of Novel Biomarkers And Gene Signatures In Barrett's Esophagus
Study ID: NCT01568723
Conditions
Interventions
Study Description
Brief Summary: The purpose of this study is to determine biomarkers which can predict response to ablation therapy in patients with Barretts esophagus.
Detailed Description: This Project is designed to identify biologically-based and clinically-useful biomarkers of tissue at risk for neoplastic progression as well as of response to ablation therapy. These results will result in improved risk stratification in BE and better targeting of resources for patients who are candidates for ablative therapy, while simultaneously providing key information regarding the origins of Barrett's esophagus.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Columbia University, New York, New York, United States
University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States
Contact Details
Name: Kenneth K Wang, MD
Affiliation: Mayo Clinic
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
